-
Christmas 2016
26 December 2016. It’s the official Christmas holiday in the USA and many parts of the world, so Science & Enterprise is taking the day off. We will continue our regular posting tomorrow. * * *
-
Genetic Tests, Elec. Health Records Show Hidden Disease
A program that connects mass genetic screening to electronic health records shows a segment of the population tested has an undiagnosed blood disorder causing high cholesterol levels.
-
Solar Reactor Devised for Small-Scale Chemical Production
An engineering group developed a solar-powered catalytic reactor that can produce small amounts of drugs and agricultural chemicals on demand.
-
Smartphone System Shown to Control Blood Glucose Levels
A bionic pancreas system using a smartphone was shown in a clinical trial to control blood glucose levels better than a commercial insulin pump in persons with type 1 diabetes.
-
Spin-Off Creates Enzyme to Prevent Celiac Disease
A spin-off enterprise from University of Washington is developing a synthetic enzyme that prevents dietary gluten from triggering symptoms of celiac disease.
-
Cell Biotech Gains Organoid Technology
A Canadian biotechnology enterprise is licensing a technology that generates organoids, three-dimensional clusters of cells from stem cells that can form into gastrointestinal organs.
-
Who Is Really Behind Efforts to Block the Medical Marijuana Industry?
Proponents of medical marijuana believe that they are safer smoking or ingesting cannabinoids than they are taking prescription drugs that carry warning after warning about potential side effects, many of which are lethal.
-
Stem Cells Shown to Regenerate Dental Pulp Tissue
A combination of dental pulp stem cells and cells from human umbilical cords, mixed with a common hydrogel, were shown in lab rats to regenerate pulp-like tissue in teeth roots.
-
New Type of Antibiotic Set for Early Trial
A clinical trial is set to test a type of drug that its developers say is designed to treat infections from bacteria resistant to earlier antibiotics.
-
Trial to Explore Microbiome Therapy for Hypertension
A clinical trial is set to begin that tests live bacteria as a treatment for hypertension, or high blood pressure, a condition affecting 1 in 3 adults in the U.S.